Philadelphia, PA (February 10, 2021)— Philadelphia-Israel Chamber of Commerce continues to grow and advance its mission to facilitate economic activities among Israeli and Greater Philadelphia innovators. On January 26th, the PICC Board installed impressive leaders as Board and Advisory Board members, primarily in life sciences, healthcare and bio.
For a second term on the PICC Board:
For first term on the PICC Board:
In addition, the following Board Members who concluded their second term on the PICC Board, have been approved to serve on the Advisory Board:
PICC welcomed new leaders to the Advisory Board:
“I am excited and honored to welcome five exceptional regional leaders to the Philadelphia-Israel Chamber of Commerce Board of Directors and five to our Advisory Board. Their wealth of knowledge and broad experience with advanced technologies, specifically in life sciences, healthcare and bio, will complement the Chamber’s mission and initiatives in the next two years. PICC champions joint business activity and ventures between and among companies, investors, researchers, executives and academics in Israel and Greater Philadelphia, Southern New Jersey and Delaware,” said Matthew I. Fingerman, ChFC®, CFP®, PICC President.
Dr. Lori Gavrin has nearly two decades of experience in drug discovery and development. She has held leadership roles within Wyeth, Pfizer and GSK in a variety of disciplines including medicinal chemistry, medical affairs, strategy, external innovation and business development. Since August 2018, Lori has served as Executive Director of Corporate and Business Development for Tmunity, a University of Pennsylvania spin-out company focused on developing T-cell therapies to treat, and ultimately cure, cancer.
Elizabeth D. Sigety, Esq. is a Partner of Fox Rothschild LLP, a national law firm with 26 offices across the United States. She is Co-Chair of Fox Rothschild’s Emerging Companies & Venture Capital practice as well as the firm’s Franchising, Licensing & Distribution practice. She is Managing Director and Co-Founder of Delaware Crossing Investor Group, an angel network providing capital and counsel to emerging companies in the Greater Philadelphia region. She is active in many organizations supporting emerging and franchise companies and a frequent speaker and writer in these areas.
Professor Matt Dane Baker, PA-C, D.H.Sc. has more than 39 years of healthcare and higher education experience, having held several positions in clinical, academic, administrative, military, and research settings. Dr. Baker currently serves as Senior Vice Provost for Academic Affairs. In this position, he oversees all academic affairs units including the registrar’s offices, enrollment management, financial aid, outcomes assessment, accreditation, study abroad, the honors program, new program development, the libraries, the Teaching and Learning Center, the Academic Success Center, the Jefferson Center for Interprofessional Education and Practice, the Dr. Robert and Dorothy Rector Clinical Skills and Simulation Center, special projects, and several external partnerships.
Sarah Goncher is Deputy General Counsel for Operations at ChristianaCare. In this role, she assists ChristianaCare leadership and caregivers address legal issues involving patient care, medical staff, employee relations, and other matters related to the operation of the health system. Prior to joining Christiana Care, Sarah was a Deputy Attorney General and Unit Head of the Health Law Unit with the Delaware Department of Justice, where she managed a team of attorneys representing the Delaware Department of Health and Social Services and the Delaware Department of Services for Children Youth and their Families. Sarah also previously worked as a staff attorney at Community Legal Aid Society, Inc.
Lawton Laurence, Sr. is Director, Applied Research and Technology at West Pharmaceutical Services, where he is responsible for the Radical and Disruptive Innovation Group within research & development. Conceived as an internal incubator for novel product concepts and business models, his group supports the strategic vision by rapidly advancing early-stage device development through a human centric design philosophy and rigorous innovation process. His team sponsors a variety of academic research programs across the globe and partners with early-stage growth companies to produce breakthrough technology.
PICC’s new Board members will contribute to the success of PICC programing in 2021, featuring innovation in cell and gene therapeutics and bio convergence, food tech, and various technologies. The PICC will also promote regional joint ventures with Israeli innovators leveraging on funding from the U.S.-Israel Binational Industrial R&D Foundation (BIRD).
Philadelphia-Israel Chamber of Commerce:
The unique mission of Philadelphia-Israel Chamber of Commerce is developing business and academic ties between Greater Philadelphia, Southern New Jersey and Delaware, and Israel. PICC is a non-profit, non-denominational, independent organization focused on creating commercial and investment opportunities between the two regions.
PICC also represents the US-Israel Binational Industrial Research and Development Foundation (BIRD), which has made more than $10 million in industrial R&D grants regionally to U.S.-Israeli technology ventures (11 grants awarded to PA, DE and SNJ 2016-2020).
For more information
Ms. Vered Nohi, Executive Director, Philadelphia-Israel Chamber of Commerce, 302.540.6374